Volume 4, Issue 3 (8-2015)
aumj 2015, 4(3): 145-149 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Mortazavi A, Fazeli F, Yousefnezhad S. Is There Any Benefit Adding Anticholinergics to Drug Regime of Patients with Benign Prostate Hyperplasia?. aumj 2015; 4 (3) :145-149
URL: http://aums.abzums.ac.ir/article-1-328-en.html
URL: http://aums.abzums.ac.ir/article-1-328-en.html
1- Department of Urology, Zahedan University of Medical Sciences, Zahedan, Iran , Parisa_Vosoughi93@yahoo.com
2- Department of Urology, Zahedan University of Medical Sciences, Zahedan, Iran
3- General Practitioner, Zahedan University of Medical Sciences, Zahedan, Iran
2- Department of Urology, Zahedan University of Medical Sciences, Zahedan, Iran
3- General Practitioner, Zahedan University of Medical Sciences, Zahedan, Iran
Abstract: (5102 Views)
Aim: the efficacy and safety of combined therapy with anticholinergics and alpha blockers in comparison with alpha blockers monotherapy among patients with BPH. Methods: We conducted a single blinded RCT and 80 patients with BPH who referred to Ali-ebn-abitaleb, Zahedan were included. One group received 0.4 mg/d Tamsulosin in addition to Tolterodine and the other group received the same doses of Tamsulosin in addition to placebo. Both groups were evaluated before and 6 months after treatment with special attention to clinical symptoms, life quality improvement and treatment satisfaction. SPSS was applied for data analysis. Results: There is no significant difference between these two groups of patients’ demographics and basic indices such as PVR, PSA and the volume of prostate. IPSS was significantly improved among patients who received Toltrodine (p=0.0008) whereas both groups showed same score before treatment. Conclusion: It seems that combined therapy with anticholinergics and alpha blockers is a safe and efficient regimen among patients with BPH, either as primary or alternative treatment after the failure of conventional treatments.
Type of Study: Research |
Subject:
Special
Received: 2015/10/10 | Accepted: 2015/10/10 | Published: 2015/10/10
Received: 2015/10/10 | Accepted: 2015/10/10 | Published: 2015/10/10
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
